EE04043B1 - H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks - Google Patents

H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Info

Publication number
EE04043B1
EE04043B1 EEP199900118A EE9900118A EE04043B1 EE 04043 B1 EE04043 B1 EE 04043B1 EE P199900118 A EEP199900118 A EE P199900118A EE 9900118 A EE9900118 A EE 9900118A EE 04043 B1 EE04043 B1 EE 04043B1
Authority
EE
Estonia
Prior art keywords
glucocorticoids
preparation
dosage form
atpase inhibitor
atpase
Prior art date
Application number
EEP199900118A
Other languages
English (en)
Estonian (et)
Other versions
EE9900118A (et
Inventor
Lennart Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900118A publication Critical patent/EE9900118A/xx
Publication of EE04043B1 publication Critical patent/EE04043B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
EEP199900118A 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks EE04043B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (2)

Publication Number Publication Date
EE9900118A EE9900118A (et) 1999-10-15
EE04043B1 true EE04043B1 (et) 2003-06-16

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900118A EE04043B1 (et) 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Country Status (34)

Country Link
EP (1) EP0946175B1 (is)
JP (1) JP4100713B2 (is)
KR (1) KR100510812B1 (is)
CN (1) CN1146416C (is)
AR (1) AR008886A1 (is)
AT (1) ATE230597T1 (is)
AU (1) AU738310B2 (is)
BR (1) BR9711896A (is)
CA (1) CA2268305C (is)
CZ (1) CZ298799B6 (is)
DE (1) DE69718347T2 (is)
DK (1) DK0946175T3 (is)
EE (1) EE04043B1 (is)
ES (1) ES2188995T3 (is)
HK (1) HK1022848A1 (is)
HU (1) HUP0000036A3 (is)
ID (1) ID23692A (is)
IL (1) IL129324A0 (is)
IS (1) IS1930B (is)
MY (1) MY117918A (is)
NO (1) NO321007B1 (is)
NZ (1) NZ334786A (is)
PL (1) PL190902B1 (is)
PT (1) PT946175E (is)
RS (1) RS49599B (is)
RU (1) RU2197966C2 (is)
SA (1) SA97180641B1 (is)
SE (1) SE9603725D0 (is)
SK (1) SK284252B6 (is)
TR (1) TR199900770T2 (is)
TW (1) TW568784B (is)
UA (1) UA59374C2 (is)
WO (1) WO1998016228A1 (is)
ZA (1) ZA978842B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
CZ2001584A3 (cs) 1998-08-18 2002-06-12 The Regents Of The University Of California Prevence tvorby hlenu v dýchacích cestách podáváním antagonistů EGF-R
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
CA2467652A1 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
US20050131026A1 (en) * 2002-03-14 2005-06-16 Atlanta Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
EP1517706A2 (en) * 2002-05-07 2005-03-30 ALTANA Pharma AG Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
US20050222193A1 (en) * 2002-05-07 2005-10-06 Guido Hanauer Novel combination for the treatment of airway disorders
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
AU2003293833B2 (en) 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
MY117918A (en) 2004-08-30
SE9603725D0 (sv) 1996-10-11
TR199900770T2 (xx) 1999-06-21
EP0946175B1 (en) 2003-01-08
CZ122999A3 (cs) 1999-09-15
RU2197966C2 (ru) 2003-02-10
AU4640997A (en) 1998-05-11
SK284252B6 (sk) 2004-12-01
UA59374C2 (uk) 2003-09-15
RS49599B (sr) 2007-06-04
AR008886A1 (es) 2000-02-23
WO1998016228A1 (en) 1998-04-23
HUP0000036A3 (en) 2003-02-28
BR9711896A (pt) 1999-08-24
IL129324A0 (en) 2000-02-17
YU16399A (sh) 2000-03-21
HUP0000036A2 (hu) 2002-05-29
HK1022848A1 (en) 2000-08-25
KR100510812B1 (ko) 2005-08-31
AU738310B2 (en) 2001-09-13
NO321007B1 (no) 2006-02-27
IS1930B (is) 2004-05-18
NO991619D0 (no) 1999-04-06
HU0000036D0 (is) 2002-05-29
EP0946175A1 (en) 1999-10-06
PL190902B1 (pl) 2006-02-28
SA97180641B1 (ar) 2005-12-18
DK0946175T3 (da) 2003-03-17
NZ334786A (en) 2000-12-22
KR20000049046A (ko) 2000-07-25
CA2268305C (en) 2006-11-28
JP4100713B2 (ja) 2008-06-11
CN1232397A (zh) 1999-10-20
EE9900118A (et) 1999-10-15
DE69718347T2 (de) 2003-08-28
NO991619L (no) 1999-04-06
CN1146416C (zh) 2004-04-21
CA2268305A1 (en) 1998-04-23
PT946175E (pt) 2003-04-30
PL332692A1 (en) 1999-09-27
CZ298799B6 (cs) 2008-02-06
SK38499A3 (en) 2000-03-13
TW568784B (en) 2004-01-01
JP2001508034A (ja) 2001-06-19
DE69718347D1 (de) 2003-02-13
ZA978842B (en) 1998-04-14
ATE230597T1 (de) 2003-01-15
ID23692A (id) 2000-05-11
IS5021A (is) 1999-04-08
ES2188995T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
EE04500B1 (et) Trombiini inhibiitorid, nende saamine ja kasutamine
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
NO971764L (no) Levedyktige, forurensningspartikkelfrie adenoviruser, deres fremstilling og anvendelse
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
EE04043B1 (et) H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks
ZA975591B (en) New amidino derivatives and their use as thrombininhibitors
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
ITTO930338A0 (it) Composizione adesiva, relativi procedimenti ed impiego
DK0799819T3 (da) 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
IS4862A (is) Amínóísókínólín og amínóþíenópýridínafleiður og notkun þeirra sem bólgueyðandi efna
FI990134A (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO990335D0 (no) Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
FI941914A (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
FI955679A0 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081001